Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on April 10th, 2015% (Agricultural Research Service, USDA)
10 April 2015. A bioengineering lab at University of Guelph in Ontario, Canada developed a quick, simple test for avian flu virus that infects poultry, including the type of virus now infecting turkeys in the U.S. and Canada. Guelph’s Bionano Lab led by engineering professor Suresh Neethirajan says a . . . → Read More: Simple Avian Flu Test Designed for Poultry
By Alan, on April 10th, 2015% Ovidiu Daescu (University of Texas, Dallas)
10 April 2015. Two University of Texas campuses, in Dallas and nearby Arlington, formed a research center to study software solutions for assistive technologies that benefit disabled and able-bodied people alike. The iPerform Center for Assistive Technologies to Enhance Human Performance, funded for five years by National . . . → Read More: North Texas Campuses Researching Assistive Technologies
By Alan, on April 9th, 2015% Nerve cells in brain illustration (NIH.gov)
9 April 2015. A new treatment in development for Alzheimer’s disease was designated an orphan drug for Fragile X syndrome, an inherited neurological disorder, by the U.S. Food and Drug Administration. Neurotrope BioScience Inc. in Newark, New Jersey, received the designation for its drug bryostatin, now in . . . → Read More: Alzheimer’s Drug Granted Orphan Status for Fragile X
By Alan, on April 9th, 2015% IntelliCare screen. Click on image for full-size view. (Google Play)
9 April 2015. A lab at Northwestern University medical school developed a collection of mobile apps for helping people cope with feelings of depression and anxiety, and is testing the apps as personalized interventions in a clinical trial. The study is led by . . . → Read More: Trial Testing Mobile Apps for Mood Management
By Alan, on April 8th, 2015% Sherry Harbin (Purdue University)
8 April 2015. A one year-old company, based on research at a Purdue University biomedical engineering lab, is producing customized biomaterials designed to form into synthetic tissue for drug discovery and toxicity testing. GeniPhys, founded by Purdue biomedical engineering professor Sherry Harbin, aims to further develop the technology, licensed . . . → Read More: Purdue Spin-Off Designing Customized Synthetic Tissue
By Alan, on April 8th, 2015% Stacie Dusetzina (Univ. of North Carolina, Chapel Hill)
8 April 2015. An analysis of cancer drug costs and reimbursement practices shows people without health insurance are paying much more for chemotherapy drugs than people covered under private insurance or Medicare. The team led by pharmacy professor Stacie Dusetzina at University of North Carolina . . . → Read More: Uninsured Patients Paying Far More for Cancer Drugs
By Alan, on April 7th, 2015% InTouch smart glucose meter (Livongo Health)
7 April 2015. Livongo Health, a developer of mobile devices to help people with chronic disorders manage their conditions, raised $20 million in its second venture financing round. Funding for the Mountain View, California start-up, founded 7 months ago, was led by venture capital company Kleiner Perkins . . . → Read More: Mobile Diabetes Device Maker Lands $20M in Venture Funds
By Alan, on April 7th, 2015% (kropekk_pl/Pixabay)
7 April 2015. A partnership between Caris Life Sciences and COTA, short for Cancer Outcomes Tracking and Analysis, is combining data on the chemical makeup of cancer patients with clinical outcomes information to create better profiles of cancer tumors and identify more personalized therapies. Financial details between Caris Life Sciences in Irving, . . . → Read More: Collaboration Collecting Data to ID Precise Cancer Meds
By Alan, on April 6th, 2015% (Scalable Health Initiative, Rice University)
6 April 2015. Engineers from Rice University in Houston wrote a series of algorithms that make it possible to calculate blood volume from facial video images rather than attaching a device to a person’s skin. The team from Rice’s Scalable Health Initiative that examines applications of technology to . . . → Read More: Algorithms Compute Blood Volume from Video Images
By Alan, on April 6th, 2015% Human chromosomes (Genome.gov)
6 April 2015. Drug maker Bristol-Myers Squibb is licensing gene therapies from biotechnology company uniQure N.V. in a deal with a total potential value of $2.3 billion, including an equity stake in uniQure. The agreement gives Bristol-Myers Squibb exclusive access to as many as 10 disease programs being developed by . . . → Read More: Bristol-Myers Squibb Licensing Gene Therapies in $2.3B Deal
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.